Infectious Diseases Search
Infectious Diseases Infectious Diseases
tinea%20unguium
TINEA UNGUIUM
Onychomycosis is a fungal infection of the nail bed, nail plate or both. It is caused by dermatophytes, non-dermatophyte molds and yeast.
Tinea unguium or dermatophytic onychomycosis is a dermatophyte infection of the nail more commonly affecting the toenails than the fingernails.
It is usually asymptomatic and patients first consult for cosmetic reasons.
It is suspected if there are changes in the 3rd or 5th toenail, involvement of the 1st and 5th toenails on the same foot and unilateral nail changes.

Tinea Unguium Drug Information

Drug Information

Indication: Dermatophytes or yeasts, mycoses & other fungi eg, Tinea capitis, corporis, manuum, barbae, cruris, pedis....

Indication: Topical treatment of dermatophyte skin infections eg, tinea corporis, cruris, manus & pedis due to Trichop...

Indication: Cap: Vulvovag & oral candidosis; dermatomycosis, plantar tinea pedis & palmar tinea manus, pityriasis ...

Indication: Tinea pedis, cruris, corporis & versicolor; cutaneous candidiasis.

Indication: Acute or recurrent genital & vag candidiasis, candidal balanitis, dermatomycosis including tinea pedis, ti...

Indication: Cryptococcosis ie, cryptococcal meningitis & infections of other sites (eg, pulmonary, cutaneous). Mainten...

Indication: Fungal skin infections including candidiasis, tinea & pityriasis versicolor.

Indication: Management of superficial candidiasis & fungal skin infections eg, mucocutaneous candidiasis, dermatophyto...

Indication: Cryptococcosis. Systemic, mucosal & vag candidiasis. Prevention of fungal infection in patients w/ maligna...

1  /  8
1  /  8
Editor's Recommendations
Most Read Articles
Can pregnant women transmit COVID-19 to their infant during delivery?
Stephen Padilla, 07 Dec 2020
A multicentre descriptive study in Spain has not detected any transmission of the novel coronavirus (COVID-19) during delivery or throughout the first month of life in the newborns. In addition, the rates of exclusive breastfeeding at discharge and at 1 month of age are lower than expected.
Systemic corticoids cut death risk in critically ill COVID-19 patients
Tristan Manalac, 22 Feb 2021
The systemic use of corticosteroids lowers 28-day all-cause mortality among patients with the novel coronavirus disease (COVID-19), as opposed to usual care or placebo, according to the REACT* meta-analysis presented at the recently concluded eCritical Care Reviews Meeting 2021 (eCCR21).
IV immunoglobulins + methylprednisolone tied to better outcomes in MIS-C
Audrey Abella, 29 Mar 2021
The addition of methylprednisolone to intravenous immunoglobulins (IVIG) was associated with more favourable fever course and secondary outcomes in multisystem inflammatory syndrome in children (MIS-C) compared with IVIG alone, a French retrospective analysis has shown.
Excess mortality exceeds reported deaths from COVID-19
Stephen Padilla, 01 Jun 2021
Nearly 1 million excess deaths have been recorded in 2020 in 29 high-income countries, with age-standardized excess death rates being higher in men than in women, a study has shown. Sex inequality in mortality has further widened in most countries in 2020.